3rd Annual Lab Operations and Facility Management for Biopharma Summit Europe 2025

Compared to five years ago, biopharma lab operations have undergone a transformation driven by tighter budgets, technological advancements, and the need for greater efficiency. Organisations today are focused on digitisation, automation, and sustainability while optimising their lab spaces and managing the ROI on their assets.

Despite challenges such as workforce reductions and economic pressures, innovations in technology and smart lab solutions are helping labs operate more efficiently and cost-effectively than ever before.

The 3rd Lab Operations and Facility Management for Biopharma Summit Europe returns to Amsterdam in 2025 with a broader focus, expanding beyond asset utility to advance site and workplace strategies.

With more strategic content than ever before, along with the likes of Novartis, Roche, GSK, AstraZeneca, Teva Pharmaceuticals, and more set to attend, join us at the annual event to explore how digital transformation, vendor engagement, lab infrastructure optimisation are contributing to operational excellence!


URLs:
Website: https://go.evvnt.com/2775707-0?pid=10018
Tickets: https://go.evvnt.com/2775707-2?pid=10018
Brochure: https://go.evvnt.com/2775707-3?pid=10018

Prices:
Conference + Workshop Day - Primary Pricing: EUR 3297.00,
Conference Only - Primary Pricing: EUR 2399.00,
Conference + Workshop - Discounted Pricing: EUR 2697.00,
Conference Only - Discounted Pricing: EUR 1999.00,
Conference + Workshop - Vendor Pricing: EUR 4597.00,
Conference Only - Vendor Pricing: EUR 3399.00

Speakers: Alexis Anchundia, Senior Facilities Engineer, Noven Pharmaceuticals, Andreas Schumacher, Global Head, Equipment and Engineering, Novartis, Andrew Palfreeman, Associate Director, R AND D Lab Core and Operations, Quell Therapeutics, Anna Greenswag, Director, Lab and Infrastructure, Ginkgo Bioworks, Christiane Glanzmann, Global Expert, Laboratory Workplace Strategy, Roche, Daniel Bass, Senior Procurement Manager, R AND D, Lab Assets and Services, GSK, Diana Mojahed, Chief Executive Officer, LightFinder, Emrah Surun, Global Alliance and Asset Manager, Roche, Jack Hawes, Director, Lab Capability and Capacity, Scientific Services, AstraZeneca, Joanna Mitchell, Head, Real Estate and Workplace Experience, Astellas Pharma, John Curran, Chief Operating Officer and Laboratory Director, Pear Bio, Kat Szoda, Vice President, Global Facilities Management and Real Estate, Teva Pharmaceuticals, Krystal Labonte, Director, Scientific Services, AstraZeneca, Liz Kentish, Managing Director, Kentish and Co., Martin Frohock, Global Workplace Director, Abcam, Richard Snell, Director, Global Scientific Services, GSK, Shaun Rhodes, Director, Supplier Relationships, Scientific Services, AstraZeneca, Simon Francis, Director, Estates and Facilities, Institute of Cancer Research